ArticleChemistry & biodiversity2026
Metabolomics Combined With Network Pharmacology to Reveal the Metabolic Differences and Underlying Anti-Inflammatory and Antipyretic Mechanisms of Berchemia lineata.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
This study explored the metabolic differences between roots and stems of Berchemia lineata, as well as the material basis and mechanism of its antipyretic and anti-inflammatory properties. Untargeted metabolomics identified 94 compounds and 12 differential metabolites, with anthraquinones abundant in roots and flavonoids dominant in stems. Combined with network pharmacology and molecular docking, key active ingredients were found to target TNF-α, IL-6 and other core genes via the PI3K-Akt pathway. Except for lyoniresinol, most active compounds exhibited good target binding activity. LPS-induced mouse experiments further validated the herb's efficacy in lowering fever and suppressing pro-inflammatory cytokines. This research elucidates the chemical disparities among different parts of Berchemia lineata and reveals its multi-component, multi-target antipyretic and anti-inflammatory mechanism, offering references for its rational development and clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.